Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted Therapy

Ovarian cancer is the deadliest of all gynecologic malignancies claiming the lives of nearly 14,000 women in the United States annually. Despite therapeutic advances, the ovarian cancer mortality rate has remained stagnant since the 1980’s. The molecular heterogeneity of ovarian cancers suggest they...

Descripción completa

Detalles Bibliográficos
Autores principales: Harbin, Laura M., Gallion, Holly H., Allison, Derek B., Kolesar, Jill M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030726/
https://www.ncbi.nlm.nih.gov/pubmed/35453890
http://dx.doi.org/10.3390/diagnostics12040842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030726/
https://www.ncbi.nlm.nih.gov/pubmed/35453890
http://dx.doi.org/10.3390/diagnostics12040842

Ejemplares similares